Tomoyuki Tsuzuki
Toyota Kosei Hospital(JP)
Publications by Year
Research Areas
Gastric Cancer Management and Outcomes, Helicobacter pylori-related gastroenterology studies, Esophageal Cancer Research and Treatment, Inflammatory Bowel Disease, Lung Cancer Treatments and Mutations
Most-Cited Works
- → AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study(2022)78 cited
- → Characteristics of Helicobacter pylori‐Induced Gastritis and the Effect of H. pylori Eradication in Patients with Chronic Idiopathic Thrombocytopenic Purpura(2004)56 cited
- → Possible involvement of neutrophil elastase in impaired mucosal repair in patients with ulcerative colitis(2002)36 cited
- → Concurrent Chemoradiotherapy with a Novel Fluoropyrimidine, S-1, and Cisplatin for Locally Advanced Esophageal Cancer: Long-Term Results of a Phase II Trial(2013)36 cited
- → Possible involvement of the interleukin-15 and interleukin-15 receptor system in a heightened state of lamina propria B cell activation and differentiation in patients with inflammatory bowel disease(2005)31 cited
- → A Phase II Multi-Center Study of Triple Therapy with Paclitaxel, S-1 and Cisplatin in Patients with Advanced Gastric Cancer(2011)26 cited
- → Esophageal cancer with colonic metastasis successfully treated by chemoradiotherapy followed by chemotherapy with S-1 and cisplatin(2004)24 cited
- → Suppressive Effects of Cyclosporine A on Neutrophils and T Cells May Be Related to Therapeutic Benefits in Patients with Steroid-Resistant Ulcerative Colitis(2002)24 cited
- → Differential roles of interleukin‐1β and interleukin‐8 in neutrophil transendothelial migration in patients with Helicobacter pylori infection(2004)12 cited
- → Randomized Phase II Study of Consecutive-Day versus Alternate-Day Treatment with S-1 as Second-Line Chemotherapy in Advanced Pancreatic Cancer(2018)9 cited